Vaccine Manufacture and Supply – Multimedia

The pandemic has ushered in a vaccines “golden era”. Long-term investment in vaccine manufacturing has been prioritized, as has the pursuit of novel vaccine platforms. In this infographic, we explore recent advances in vaccine research and development.

This eBook highlights ways that you can level up your vaccine research with selected bioreactor tools to fit your vaccine development workflow.

Vaccines are critical for the prevention of infectious diseases and improvement of global health. Better understanding of the immune system and the availability of advanced structural biology tools and genetic delivery systems have unlocked new possibilities to improve vaccine development.

Speaking at the Vaccine Research & Development 2022 online symposium, Zoltan Kis from the University of Sheffield discussed digital design for RNA vaccine and therapeutic production.

Download this listicle to explore the early days of vaccination, how vaccine production leapt forward, and a new era in vaccines and future challenges.

Download this eBook to learn how innovations in purification technology can address global vaccine development needs.

Illustrating the realities of (and threats to) global vaccine supply chains, technologist and TED Fellow Nithya Ramanathan describes how smart sensors placed in fridges that store medical supplies can provide crucial, real-time data and ensure people get the life-saving care they need.

Download this eBook to explore mRNA vaccine technology applications beyond COVID-19, vaccine types, administration routes, vaccine manufacturing, and much more.

This infographic provides an overview of vaccine development history, exploring how manufacturing pipelines differ for "traditional" and "new-era" vaccines, and how these processes can be accelerated.

Accelerated timelines are critical when responding to an outbreak and efficient vaccine manufacturing is required to enable a quicker transition from research to the clinic, saving lives. mRNAs allow biotechnology companies to develop vaccines in response to pandemics, such as COVID-19, in a matter of weeks.